Loading…
IOL Chemicals and Pharmaceuticals (IOLCP)₹202.95+10.13%Pharmaceuticals
IOL Chemicals and Pharmaceuticals is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 29.4 against a peer median of 39.9, and ROCE of 11.1% against a peer median of 15.0%, and latest-quarter sales growth of 40.1% against a peer median of 28.1%. By market cap it is #5 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bliss GVS Pharma | 6,947 | 43.0 | 17.0 | 11.8 | 0.02 | 0.2 | 925 | 135 | 28.1 | 82.7 | vs IOLCP |
| Sun Pharma Advanced Research Company | 6,830 | 4.3 | 164.1 | 278.9 | 0.42 | 0.0 | 1,882 | 1,556 | 299.7 | — | vs IOLCP |
| FDC | 6,425 | 20.6 | 15.0 | 11.3 | 0.01 | 1.3 | 2,173 | 282 | 20.8 | 74.8 | vs IOLCP |
| Innova Captab | 6,118 | 39.9 | 15.0 | 13.7 | 0.32 | 0.2 | 1,627 | 141 | 33.8 | 42.0 | vs IOLCP |
| IOL Chemicals and Pharmaceuticals | 5,967 | 29.4 | 11.1 | 8.4 | 0.08 | 0.5 | 2,312 | 138 | 40.1 | 116.5 | — |
| Morepen Laboratories | 5,433 | 29.2 | 8.0 | 5.3 | 0.17 | 0.2 | 1,808 | 96 | 80.9 | 117.0 | vs IOLCP |
| Senores Pharmaceuticals | 5,417 | 40.6 | 15.0 | 13.5 | 0.37 | 0.0 | 632 | 122 | 18.6 | 23.4 | vs IOLCP |
| Orchid Pharma | 5,291 | 421.0 | 2.0 | 1.3 | 0.28 | 0.0 | 1,229 | 10 | 15.5 | — | vs IOLCP |
| Supriya Lifescience | 5,082 | 24.3 | 25.1 | 19.1 | 0.00 | 0.2 | 826 | 209 | 50.7 | 48.1 | vs IOLCP |
| SMS Pharmaceuticals | 4,809 | 46.8 | 13.0 | 14.2 | 0.46 | 0.1 | 886 | 102 | 5.6 | 4.9 | vs IOLCP |
| Gufic Biosciences | 4,760 | 64.8 | 12.0 | 10.2 | 0.61 | 0.0 | 948 | 64 | 16.6 | 69.1 | vs IOLCP |
| Peer median | 5,433 | 39.9 | 15.0 | 11.8 | 0.28 | 0.2 | 1,229 | 135 | 28.1 | 69.1 |
Listed companies closest to IOL Chemicals and Pharmaceuticals in Pharmaceuticals include Bliss GVS Pharma, Sun Pharma Advanced Research Company, FDC, Innova Captab, Morepen Laboratories, Senores Pharmaceuticals, Orchid Pharma, Supriya Lifescience.
Bliss GVS Pharma, with a market cap of ₹6,947 Cr.
IOL Chemicals and Pharmaceuticals trades at a P/E of 29.4; the median of its peer set is 39.9. A P/E above or below the median is a description, not a judgement on value.
IOL Chemicals and Pharmaceuticals' return on capital employed is 11.1%, below the peer median of 15.0%.